How his second time bet on Infosys didn’t work out and why getting out while the going was good turned Berger Paints into his best investment
Mankind Pharma made it big in small towns, but can its magic help it conquer the bigger markets?
Can Sun Pharma’s Dilip Shanghvi work his merger magic on Ranbaxy?
KPIT’s niche business model and attractive valuation make it a sound bet
Akhil Dhawan on his day out with Buffett
At Venture Intelligence’s Apex Summit, private equity experts reviewed the prospects for the sector
A number of private equity investors are stuck in the middle, struggling to find profitable exits